While widespread vaccination is key in our fight against COVID-19, people who are infected still need better treatment to improve their chance of survival and making a full recovery.
Early on, the world had high hopes for a range of repurposed medications which had previously been approved to treat other conditions – including hydroxychloroquine, remdesivir and ivermectin – to treat COVID-19. But the results have been disappointing.
Diseases caused by viruses are among the most difficult to treat, due to their ability to invade and repurpose infected cells. This limits the ability for drugs to directly act on the virus.
Yet researchers around the world are finding ways to overcome these barriers and directly target the coronavirus, including in Australia. So what’s being developed here and how do they work?
Australia
United-states
Melbourne
Victoria
Sydney
New-south-wales
Greece
Australian
Greek
Vasso-apostolopoulos
Victoria-university
Astrazeneca